Edwards Lifesciences

Latest news

• JPMorgan Adjusts Price Target on Edwards Lifesciences to $105 From $100, Keeps Overweight Rating (opens in a new tab)

  marketscreener.com · Oct 2, 2026

• Edwards Lifesciences wins FDA approval for AUTUS (opens in a new tab)

  Mugglehead Investment Magazine · Oct 2, 2026

• Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients (opens in a new tab)

  Business Wire · Oct 1, 2026

• Edwards Lifesciences Receives FDA Approval For AUTUS Size-Adjustable Valve (opens in a new tab)

  marketscreener.com · Oct 1, 2026

• Wall Street Zen downgrades Edwards Lifesciences stock to Hold (opens in a new tab)

  AD HOC NEWS · Oct 1, 2026

• Non-operating income (total) of Edwards Lifesciences Corporation – HAN:EWL (opens in a new tab)

  TradingView · Sep 29, 2026

• Edwards Lifesciences stock at USD 86.83 on September 28, 2026 (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• Edwards Lifesciences stock last at USD 86.52, up 0.92 percent in New York trading (opens in a new tab)

  AD HOC NEWS · Sep 25, 2026

• Edwards Lifesciences stock falls 1.26 percent on legal news (opens in a new tab)

  AD HOC NEWS · Sep 24, 2026

• Edwards Lifesciences stock heads into the open after market drop (opens in a new tab)

  AD HOC NEWS · Sep 24, 2026

• Andra AP fonden Boosts Stake in Edwards Lifesciences Corporation $EW (opens in a new tab)

  MarketBeat · Sep 23, 2026

• Edwards Lifesciences stock gains 1.26 percent near its yearly high (opens in a new tab)

  AD HOC NEWS · Sep 22, 2026

• Edwards Lifesciences stock holds steady after July-quarter earnings beat (opens in a new tab)

  AD HOC NEWS · Sep 21, 2026

• Edwards Lifesciences stock before the bell after a 0.0 percent move. (opens in a new tab)

  AD HOC NEWS · Sep 21, 2026

• Nykredit A S Makes New Investment in Edwards Lifesciences Corporation $EW (opens in a new tab)

  MarketBeat · Sep 20, 2026

• Edwards Lifesciences stock gains 4 percent as CMS decision underpins growth story (opens in a new tab)

  AD HOC NEWS · Sep 17, 2026

• Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead (opens in a new tab)

  TradingView · Sep 17, 2026

• Bank of America Corp DE Takes $605.40 Million Position in Edwards Lifesciences Corporation $EW (opens in a new tab)

  MarketBeat · Sep 16, 2026

• Edwards Lifesciences stock steadies after insider tax-withholding transactions (opens in a new tab)

  AD HOC NEWS · Sep 15, 2026

• Stock Traders Purchase Large Volume of Edwards Lifesciences Call Options (NYSE:EW) (opens in a new tab)

  MarketBeat · Sep 14, 2026

• Corient Private Wealth LP Acquires 227,947 Shares of Edwards Lifesciences Corporation $EW (opens in a new tab)

  MarketBeat · Sep 14, 2026

• Engineers Gate Manager LP Sells 81,590 Shares of Edwards Lifesciences Corporation $EW (opens in a new tab)

  MarketBeat · Sep 11, 2026

• Edwards Lifesciences Comments on TAVR National Coverage Decision (opens in a new tab)

  Business Wire · Sep 10, 2026

• Edwards Lifesciences praises CMS NCD on transcatheter aortic valve replacement (opens in a new tab)

  Seeking Alpha · Sep 10, 2026

• Is Edwards Lifesciences Stock Underperforming the Dow? (opens in a new tab)

  Yahoo Finance · Sep 8, 2026

• Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders? (opens in a new tab)

  PR Newswire · Sep 7, 2026

• Edwards Lifesciences Corporation $EW Shares Acquired by Saudi Central Bank (opens in a new tab)

  MarketBeat · Sep 7, 2026

• Edwards Lifesciences: $20 Billion TAM And A Meaningful Opportunity To Compound (NYSE:EW) (opens in a new tab)

  Seeking Alpha · Sep 7, 2026

• Vancity Investment Management Ltd Boosts Stake in Edwards Lifesciences Corporation $EW (opens in a new tab)

  MarketBeat · Sep 7, 2026

• Azimuth Capital Investment Management LLC Decreases Stock Position in Edwards Lifesciences Corporation $EW (opens in a new tab)

  MarketBeat · Sep 6, 2026